It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it . The article may be deleted if this message remains in place for seven days, i.e., after 23:35, 16 October 2025 (UTC). Find sources: "Oklahoma CyberKnife" – news · newspapers · books · scholar · JSTOR Nominator: Please consider notifying the author/project: {{ subst:proposed deletion notify |Oklahoma CyberKnife|concern=No evidence of notability; sources are routine local coverage}} ~~~~ |
 | This article needs additional citations for verification .(July 2012) |
| Industry | Healthcare |
|---|---|
| Founded | July 2008 |
| Headquarters | 6802 South Olympia Avenue, Suite G100, Tulsa, OK, , |
Key people | Medical Director: Dr. Diane Heaton Radiation Oncologist: Dr. Joshua Garren |
| Website | www |
Oklahoma CyberKnife is a cancer treatment center based in Oklahoma. The center treats malignant and benign tumors in the lungs, spine, brain, liver, pancreas, eye, prostate and kidney using CyberKnife technology. Oklahoma CyberKnife has treated patients from around Oklahoma as well as patients from bordering states.
Oklahoma CyberKnife opened in 2008 as part of Hillcrest Medical Center. In 2009, the center performed the highest number of lung-cancer treatments of any CyberKnife center internationally. Lung tumors continue to make up a majority of cases treated at Oklahoma CyberKnife. [1]
In 2012, Oklahoma CyberKnife began treating prostate patients with Medicare coverage provided they were participants in a clinical trial. [2]
Dr. Diane Heaton, Oklahoma CyberKnife's medical director, is an expert in the treatment of trigeminal neuralgia, a neurological disorder. She appeared at the 2012 annual meeting of the CyberKnife Society to present her clinical findings from a study examining pain relief in 19 trigeminal neuralgia patients following CyberKnife treatment. [3]
